HyperBranch Medical Technology

HyperBranch Medical Technology is a biotechnology startup founded in 2003 that focuses on developing innovative medical solutions for wound care and surgical recovery. The company's products cater to the traumatic or surgically induced wound market, with offerings such as OcuSeal, a liquid ocular bandage applied directly on the eye's surface, and Adherus Dural Sealant, which aids in dural repair during cranial and spinal surgeries. Additionally, they provide Adherus Hernia Mesh Fixation, an alternative device for hernia repair procedures. The company secured a $2.00M Series B investment on 13 December 2013. Despite lacking specific headquarter information, HyperBranch Medical Technology has positioned itself as a key player in the Medical Devices, Biotechnology, and Health Care industries.